As the calendar turns another page and 2013 gets underway in earnest, Liftstream is pleased to once again be leading another programme of recruitment for Celgene. Continuing a recruitment relationship that dates back as far as 2006, Liftstream has continuously throughout that time been a recruitment partner to Celgene in Europe. This has resulted in multiple phases of substantial recruitment involving very many complex skill-sets which could only be acquired by proactive and rigorous searching in international markets.
Today, we begin a new phase of recruiting regulatory affairs jobs which are pivotal to Celgene’s extensive growth. Celgene’s CEO Bob Hugin last week presented at the JP Morgan Healthcare Conference a very positive future for the company over the next 4-5 years, including major new drug approvals and sales estimated to double, meaning a very exciting opportunity for Liftstream to be furthering its support of Celgene’s growth.
Liftstream, since its inception, has been committed to proving the value of our partnership approach, showing how it not only delivers recruiting results but how it also reduces other inherent risks in the recruitment procedure. This sustained performance alongside an ability to reduce long-term costs and improve the economic models of effective talent acquisition, are clearly proven by our significant long-term success with Celgene.